Improvita Celebrates ZELSUVMI™ FDA Approval for the Treatment of Molluscum Contagiosum
MADISON, Wis., January 25, 2024 — Improvita, Inc., a Madison-based company affiliated with Innovenn, Inc., that focuses on human factors testing, ethnographic field research, user interface and user experience testing for medical devices, software as a medical device (SaMD), and combination drug/medical device products, is pleased to announce that its partner, Ligand Pharmaceuticals, has received […]
